DK1345900T3 - Guanidin- og amidinderivater som faktor XA-inhibitorer - Google Patents

Guanidin- og amidinderivater som faktor XA-inhibitorer

Info

Publication number
DK1345900T3
DK1345900T3 DK01984775T DK01984775T DK1345900T3 DK 1345900 T3 DK1345900 T3 DK 1345900T3 DK 01984775 T DK01984775 T DK 01984775T DK 01984775 T DK01984775 T DK 01984775T DK 1345900 T3 DK1345900 T3 DK 1345900T3
Authority
DK
Denmark
Prior art keywords
guanidine
inhibitors
factor
amidine derivatives
amidine
Prior art date
Application number
DK01984775T
Other languages
Danish (da)
English (en)
Inventor
David William Will
Hans Matter
Anuschirwan Peyman
Marc Nazar
Hans-Peter Nestler
Fahad Al-Obeidi
Uwe Gerlach
Gerhard Zoller
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1345900T3 publication Critical patent/DK1345900T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK01984775T 2000-12-06 2001-11-28 Guanidin- og amidinderivater som faktor XA-inhibitorer DK1345900T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00126750 2000-12-06
PCT/EP2001/013874 WO2002046159A1 (en) 2000-12-06 2001-11-28 Guanidine and amidine derivatives as factor xa inhibitors

Publications (1)

Publication Number Publication Date
DK1345900T3 true DK1345900T3 (da) 2007-05-21

Family

ID=8170585

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01984775T DK1345900T3 (da) 2000-12-06 2001-11-28 Guanidin- og amidinderivater som faktor XA-inhibitorer

Country Status (26)

Country Link
US (2) US20020173656A1 (et)
EP (1) EP1345900B1 (et)
JP (1) JP4274522B2 (et)
KR (1) KR20040015036A (et)
CN (1) CN1479722A (et)
AR (1) AR033684A1 (et)
AU (2) AU3320602A (et)
BR (1) BR0115938A (et)
CA (1) CA2430518C (et)
CZ (1) CZ20031554A3 (et)
DE (1) DE60126143T2 (et)
DK (1) DK1345900T3 (et)
EE (1) EE200300192A (et)
ES (1) ES2278798T3 (et)
HR (1) HRP20030447A2 (et)
HU (1) HUP0302604A3 (et)
IL (2) IL156214A0 (et)
MX (1) MXPA03004848A (et)
NO (1) NO20032489L (et)
NZ (1) NZ526269A (et)
PL (1) PL362320A1 (et)
PT (1) PT1345900E (et)
RU (1) RU2003120070A (et)
SK (1) SK6862003A3 (et)
WO (1) WO2002046159A1 (et)
ZA (1) ZA200303847B (et)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004014844A2 (en) * 2002-08-09 2004-02-19 Transtech Pharma, Inc. Aryl and heteroaryl compounds and methods to modulate coagulation
US7405210B2 (en) 2003-05-21 2008-07-29 Osi Pharmaceuticals, Inc. Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
US7459472B2 (en) * 2003-08-08 2008-12-02 Transtech Pharma, Inc. Aryl and heteroaryl compounds, compositions, and methods of use
US7208601B2 (en) * 2003-08-08 2007-04-24 Mjalli Adnan M M Aryl and heteroaryl compounds, compositions, and methods of use
CA2531796A1 (en) * 2003-08-08 2005-02-17 Transtech Pharma, Inc. Aryl and heteroaryl compounds, compositions, and methods of use
US8603481B2 (en) * 2003-10-10 2013-12-10 Chugai Seiyaku Kabushiki Kaisha Therapeutic agents for solid tumors
DE602005023965D1 (de) 2004-03-08 2010-11-18 Prosidion Ltd Pyrrolopyridin-2-carbonsäurehydrazide als inhibitoren von glykogenphosphorylase
WO2006059164A2 (en) 2004-12-02 2006-06-08 Prosidion Limited Pyrrolopyridine-2-carboxylic acid amides
DE102006048300A1 (de) * 2006-01-26 2007-08-02 Hellstern, Peter, Prof. Dr.med. Inhibitoren des Blutgerinnungsfaktors Xa zur Verwendung als Antikoagulans
WO2010098866A1 (en) 2009-02-27 2010-09-02 Supergen, Inc. Cyclopentathiophene/cyclohexathiophene dna methyltransferase inhibitors
US8507640B2 (en) 2010-08-19 2013-08-13 International Business Machines Corporation Methods of ring opening polymerization and catalysts therefor
JO3407B1 (ar) 2012-05-31 2019-10-20 Eisai R&D Man Co Ltd مركبات رباعي هيدرو بيرازولو بيريميدين
MA49566A (fr) 2017-07-11 2020-05-20 Vertex Pharma Carboxamides utilisés en tant qu'inhibiteurs des canaux sodiques
WO2019071073A1 (en) 2017-10-06 2019-04-11 Forma Therapeutics, Inc. INHIBITION OF THE SPECIFIC PEPTIDASE OF UBIQUITIN
DK3860989T3 (da) 2018-10-05 2023-05-01 Forma Therapeutics Inc Kondenserede pyrroliner der fungerer som inhibitorer af ubiquitin-specifik protease 30 (usp30)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201303B (et) * 1990-07-05 1993-03-01 Hoffmann La Roche
US5506134A (en) 1990-10-22 1996-04-09 Corvas International, Inc. Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex
US5833982A (en) 1991-02-28 1998-11-10 Zymogenetics, Inc. Modified factor VII
US5788965A (en) 1991-02-28 1998-08-04 Novo Nordisk A/S Modified factor VII
ES2103181B1 (es) * 1994-08-01 1998-04-01 Menarini Lab Amidas naftalenicas con accion antagonista de los leucotrienos.
CN1181091C (zh) * 1994-04-26 2004-12-22 西莱克泰德公司 因子Xa抑制剂
US5792769A (en) * 1995-09-29 1998-08-11 3-Dimensional Pharmaceuticals, Inc. Guanidino protease inhibitors
GB9602166D0 (en) * 1996-02-02 1996-04-03 Zeneca Ltd Aminoheterocyclic derivatives
TW542822B (en) * 1997-01-17 2003-07-21 Ajinomoto Kk Benzamidine derivatives
EP1007037A4 (en) * 1997-06-26 2004-10-06 Lilly Co Eli ANTITHROMBOTIC AGENTS
PL344056A1 (en) 1998-03-23 2001-09-24 Aventis Pharm Prod Inc Piperididinyl and n-amidinopiperidinyl derivatives
US20020016339A1 (en) * 1998-03-23 2002-02-07 Klein Scott I. Piperididinyl and N-amidinopiperidinyl derivatives
EP0987274A1 (en) 1998-09-15 2000-03-22 Hoechst Marion Roussel Deutschland GmbH Factor VIIa Inhibitors
CA2385592C (en) * 1999-09-17 2011-01-11 Bing-Yan Zhu Benzamides and related inhibitors of factor xa

Also Published As

Publication number Publication date
NO20032489D0 (no) 2003-06-02
IL156214A (en) 2010-05-31
SK6862003A3 (en) 2004-02-03
DE60126143T2 (de) 2007-11-15
AR033684A1 (es) 2004-01-07
ZA200303847B (en) 2004-04-15
PL362320A1 (en) 2004-10-18
HRP20030447A2 (en) 2005-04-30
HUP0302604A3 (en) 2005-09-28
JP2004515492A (ja) 2004-05-27
KR20040015036A (ko) 2004-02-18
RU2003120070A (ru) 2004-12-27
US20020173656A1 (en) 2002-11-21
CN1479722A (zh) 2004-03-03
MXPA03004848A (es) 2003-08-19
WO2002046159A1 (en) 2002-06-13
DE60126143D1 (de) 2007-03-08
EP1345900B1 (en) 2007-01-17
AU2002233206B2 (en) 2006-06-22
EP1345900A1 (en) 2003-09-24
NZ526269A (en) 2004-11-26
EE200300192A (et) 2003-08-15
IL156214A0 (en) 2003-12-23
CA2430518A1 (en) 2002-06-13
PT1345900E (pt) 2007-03-30
US7435747B2 (en) 2008-10-14
US20050143419A1 (en) 2005-06-30
BR0115938A (pt) 2003-12-23
CA2430518C (en) 2010-06-15
ES2278798T3 (es) 2007-08-16
AU3320602A (en) 2002-06-18
NO20032489L (no) 2003-07-25
JP4274522B2 (ja) 2009-06-10
CZ20031554A3 (cs) 2003-08-13
HUP0302604A2 (hu) 2003-11-28

Similar Documents

Publication Publication Date Title
NO20001687D0 (no) Benzamidinderivater som faktor Xa-inhibitorer
NO20021230L (no) Faktor Xa inhibitorer
NO20041163L (no) Laktam-inneholdende forbindelser og derivater derav som faktor XA-inhibitorer
NO20042592L (no) Indol-2-karboksamider som faktor XA inhibitorer
DK0991638T3 (da) Hidtil ukendte guanidinmimetika som faktor Xa-inhibitorer
DK1526132T3 (da) Substituerede oxazolidinoner og deres anvendelse som faktor Xa-hæmmer
NO20013072L (no) Nitrogenholdige heterocykler som faktor Xa-inhibitorer
NO20034439D0 (no) Benzamidinderivater
NO20026010D0 (no) Substituerte quinazolinderivater og deres anvendelse som inhibitorer
ATE372988T1 (de) Pyrimidin-derivate
ATE266873T1 (de) Beschichtete gegenstände
NO20024997D0 (no) 2-guanidino-4-arylkinazoliner som NHE-3-inhibitorer
DK1345900T3 (da) Guanidin- og amidinderivater som faktor XA-inhibitorer
NO20033350L (no) Imidazolyl-derivater som kortikotropin-frigjörende faktor inhibitorer
NO20025810L (no) Faktor VIIA-inhibitoriske (tio)ureaderivater, deres fremstilling og anvendelse
NO20042990L (no) Pyrrolidin-2-oner som faktor XA inhibitorer
DK1189929T3 (da) Faktor VIIa-inhibitorer
NO20014234D0 (no) Pyrazol-3-on-derivater som faktor-Xa-inhibitorer
NO20032754L (no) Urea- og/eller uretanderivater som integrininhibitorer
NO20030796D0 (no) Aza-aminosyrederivater (faktor Xa-inhibitorer 15)
DE60206376D1 (de) Faktor xa inhibitor
DK1200409T3 (da) Substituerede isoquinolinderivater og deres anvendelse som krampestillende midler
NO20020592D0 (no) Fluorenderivater som integrininhibitorer
IS6418A (is) Sakkarínafleiður sem elastasatálmar, virkir í munni
AU2000229045A1 (en) Benzimidazole derivatives and their use as factor xa inhibitors